Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Spain Pharmaceutical Pricing & Reimbursement Guide 2016 - Research and Markets

Research and Markets
Posted on: 05 Oct 16

Research and Markets has announced the addition of the "IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Spain" report to their offering.

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Key Topics Covered:

1. HEALTHCARE SYSTEM

Provision & Funding

National Health Service

Decentralisation

Funding

Provision

2. PRICING

Prescription Drugs

Reimbursed Drugs

Non-reimbursed Drugs

Mandatory Distribution Chain Discounts

Generic Drugs

Hospital Drugs

OTC Drugs

3. REIMBURSEMENT

Admission to Reimbursement

Hospital Reimbursement

Formularies

Funding

Out-patient Dispensing

Changes in Reimbursement Status

Changes in Reimbursement Prices

Price Revisions

Price Increases

Price Decreases

Mandatory Distribution Chain Discounts

4. PHARMACOECONOMICS

Pharmacoeconomic Requirements

HTA Developments

Draft Royal Decree

5. PRICE BUILD UP

Wholesalers

Margins

Mandatory Discounts

Background

Retail Pharmacies

Margins

Mandatory Discounts

Other Discounts

Pharmacy Clawbacks

Extra Financial Support

Pharmacy Provision & Regulation

E-pharmacy

Unit Dose Dispensing

Dispensing Doctors

Sales Tax

6. COST CONTAINMENT

Industry Paybacks

Risk-sharing/Maximum Expenditure Agreements

Industry Pact

Promotional Costs

Patient Co-payments

Pharmaceuticals

Healthcare

Prescribing Controls

National Controls

Generics

Rx-to-OTC Switches

Parallel Trade

Drug Tracing

7. FUTURE DEVELOPMENTS

Outlook

Royal Decree on Pricing and Reimbursement

Government Pacts with Industry

National vs Regional Control

8. NAMES & ADDRESSES

For more information about this report visit http://www.researchandmarkets.com/research/jz97n2/ims

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161005006098/en/

Business Wire
www.businesswire.com

Last updated on: 05/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.